APTEVO THERAPEUTICS INC

Historical 13F Holders

Symbol
APVO
CUSIP
03835L504
All holders as of
Q3 2025
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 03835L504 since 12/18/2024, largest first.

Filer % of Class Filed
YA II PN, Ltd. 13G
10.0% 7/8/2025
Event 6/16/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
CVI Investments, Inc. 13G/A
Amended under CUSIP 03835L702 on 2/17/2026
9.9% 8/14/2025
Event 6/30/2025
L1 Capital Global Opportunities Master Fund, Ltd. 13G/A 4.99% 8/14/2025
Event 8/14/2025
Bank of America Corp /DE/ 13G/A 0% 11/7/2025
Event 10/31/2025
Point72 Asset Management, L.P. 13G/A
0% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 12 494 k $717 k
2025 Q2 7 5.04 k $15.4 k